There is evidence for neurodevelopment disturbances in schizophrenia. In rats, a neonatal basolateral amygdala lesion induces behavioural features in adults reminiscent of the symptomatology of schizophrenia. Dopamine plays a key role in the pathogenesis of schizophrenia, and cannabis use has been implicated in the risk for developing schizophrenia. The effects of an excitotoxic, bilateral basolateral amygdala lesion on postnatal days 7 or 21 were compared when the rats were adult. The behavioural response to a novelty challenge and the level of dopamine receptors and cannabinoid receptors in the brain using in-vitro autoradiography was determined. In brain tissue punches concentrations of monoamines and metabolites were determined by high-performance liquid chromatography. The neonatal lesion, but not the later lesion induced behavioural hyperactivity and biochemical effects. The neonatal lesion reduced the density of dopamine D 2 -like, but not D 3 -, and less markely D 1 -like receptors and increased dopamine turnover. These effects were observed in the mesolimbic, but not in the striatal regions. In contrast, density of cannabinoid receptors was increased in the striatal, but not the mesolimbic regions of these animals. Noradrenergic neurotransmission was reduced in both regions. The present findings contribute to the idea that the neonatal basolateral amygdala lesion induces features in adults reminiscent of the neurodevelopmental disturbances in schizophrenia, with a focus on the amygdalaprefrontal cortex-nucleus accumbens circuit.
Introduction
Injury to the developing brain could result in changes in neuronal connectivity and may thus have widespread functional implications. This has been demonstrated in animal studies involving lesioning of the medial temporal lobe in neonates. Lipska and Weinberger (2000) showed that lesioning of the neonatal ventral hippocampus renders the adult rat hyper-responsive to pharmacological stressors, and affects the function of cortical and subcortical systems. We performed similar studies in which the basolateral amygdala was lesioned on postnatal day (PD) 7. In adulthood these rats showed locomotor stereotypy, decreased habituation, impaired social behaviour, altered stress responsiveness, hyper-responsivity to apomorphine and phencyclidine, and a disrupted prepulse inhibition of the acoustic startle response. These effects, with the exception of part of the changes in social behaviour, were not seen in animals receiving the same lesion on PD 21, indicating that the effects were due to functional neurodevelopmental consequences of the lesion rather than amygdala damage per se (Daenen et al., , 2002a (Daenen et al., ,b, 2003a Diergaarde et al., 2004 ; Terpstra et al., 2003 ; Wolterink et al., 2001) . Indeed, neuroanatomical studies have revealed that the reciprocal connections between the basolateral amygdala and the medial prefrontal cortex (mPFC), but not those between the basal lateral amygdala and the subcortical and thalamic regions, changed markedly between PD 7 and 21 (Bouwmeester et al., 2002a,b) . This suggests that the early lesions could result in disturbed neurodevelopment of the mPFC which may be the underlying cause of the behavioural deficits.
In the present series of experiments we focused on changes in monoamine and cannabinoid brain systems in adult rats with a neonatal lesion of the basolateral amygdala. The rationale of the studies was twofold. First, the mPFC has distinct functional connections with nigrostriatal and mesolimbic areas, in which dopaminergic and cannabinoid systems play a prominent role (Carr and Sesack, 2000 ; Herkenham et al., 1991 ; Tsou et al., 1998 ; Tzschentke and Schmidt, 2000) . Assuming that the mPFC is disturbed in the neonatally lesioned rats, we hypothesized that as a consequence monoamine and cannabinoid systems in subcortical regions of adult rats may be affected as well. Second, the early amygdala lesion model has been put forward as a neurodevelopmental animal model of some aspects of schizophrenia and autism ; see also Lipska and Weinburger, 2000) . Several hypotheses concerning the pathogenesis of schizophrenia have been suggested of which the neurodevelopment and the dopamine (DA) hypotheses are the most prominent (Duncan et al., 1999 ; Weinburger, 1987) . In its current form, the DA hypothesis postulates hyperactivity of the mesolimbic DA system, associated with positive symptomatology, and a hypodopaminergic state in frontal cortical terminal fields, associated with negative symptomatology. In addition, recent studies suggest an association between cannabis use and schizophrenia, either as risk or precipitating factor or attenuating negative symptomatology (Arsenault et al., 2002 ; Krystal et al., 1999 ; Semple et al., 2005 ; Veen et al., 2004) .
The main aim of the experiments was to determine the density of DA receptors (D 1 -like and D 2 -like) and cannabinoid receptors (CB 1 ) in specific brain regions using in-vitro autoradiography in adult rats with or without an excitotoxic, basolateral amygdala lesion induced at PD 7 and 21. In further experiments we determined the density of D 3 receptors and the levels of DA, noradrenaline (NA) and their metabolites and of the serotonin metabolite 5-hydroxyindoloacetic acid (5-HIAA) in some restricted brain areas of adult rats with a basolateral amygdala lesion induced at PD 7.
Materials and methods

Animals and animal surgery
Male offspring of pregnant Wistar/UWU rats (GDL, Utrecht, The Netherlands) were used. Mothers, obtained at 18 d gestation, were housed individually in macrolon cages measuring 40r26r20 cm (lrwrh) at controlled temperature (22¡1 xC) and light conditions (lights on 07:00 hours, lights off 19:00 hours). Standard food (Hope Farms, Woerden, The Netherlands) and tap water were provided at libitum. The rats were weaned at PD 21. Experimental procedures were approved by the Ethics Committee on Animal Experiments of Utrecht University.
Rats (PD 7 or PD 21) were anaesthetized with fentanyl (0.3 mg/kg s.c.). Naloxone (0.1 mg/kg s.c.) was used post-surgically to antagonize the effects of fentanyl. At PD 7, pups were placed in specially designed condensation silicone moulds and fixed in a stereotactic apparatus. Rats operated on at PD 21 were immobilized in a stereotactic apparatus directly. A midline skin incision was made, the skull was perforated and ibotenic acid [3 mg/0.3 ml over 2 min (PD 7) or 4 mg/0.3 ml over 2 min (PD 21)] or 0.1 m Dulbecco's phosphate buffered saline (shamoperated) (pH 7.4) was injected bilaterally in the basolateral amygdala by a microinfusion pump through 0.33 mm stainless steel cannulae [coordinates relative to bregma : APx1.0 mm, ML+3.8 mm, DVx 6.0 mm, cannulae/4x (PD 7) or : APx2.0 mm, ML+ 4.0 mm, DVx6.8 mm, cannulae/0x (PD 21)]. The cannulae were withdrawn 4 min after completion of the infusion ).
Selection
Only those rats in which the basolateral amygdala was bilaterally damaged, with minor or no damage to surrounding amygdaloid nuclei and the ventral hippocampus were used in the experiments ( Fig. 1a-c ; Paxinos and Watson, 2004 ).
Behaviour
Rats were tested on PD 63 (between 12:00 and 15:00 hours) in a Plexiglas open cylinder (diameter 18.5 cm, height 30 cm) in a sound-attenuated observation room. Three hours before testing the rats were brought to the observation room. Twenty minutes after administration of saline (1 ml/kg s.c.) the rats were placed in the novel arena, according to the procedure employed in previous behavioural experiments.
according to the position of the hind legs), number and duration of rearings (standing on the hind limbs), sniffing (only at the bottom of the arena) and grooming were measured ).
Histology and autoradiography
The day following behavioural testing the rats were decapitated. Brains were removed, frozen in isopentane (x25 xC) and stored at x80 xC before sectioning. Slices (20 mm ; 280 mm apart) were thawmounted onto 1 % gelatin/chrome-alum-coated slides. One series of sections was stained with haematoxylin acid/eosin.
For the D 2 /D 3 /D 4 receptor (D 2 -like), slices were preincubated for 60 min at room temperature in 50 mM Tris-HCl buffer (pH 7.4) containing (mM) : NaCl, 120 ; KCl, 5 ; CaCl 2 , 2, and MgCl 2 , 1. Sections were then incubated at room temperature for 60 min in fresh buffer containing 1 nM radiolabelled nemonapride ([ 3 H]YM-09151-2 ; 85.5 Ci/mmol) with DTG (0.5 mM) and pindolol (0.1 mM) to mask sigma s 1 /s 2 sites and serotonin 5-HT 1A receptors respectively and prevent their labelling by the radioligand (Lahti et al., 1995 ; Tarazi et al., 1997 ; Yokoyama et al., 1994) . Nonspecific binding was determined with excess (10 mM) S(x)-sulpiride. After incubation slides were washed twice for 5 min in ice-cold buffer, dipped in ice-cold water and dried under a stream of cold air (Tarazi et al., 1998) .
For the DA D 1 /D 5 receptor (D 1 -like) the same protocol was used. The incubation buffer contained 1 nM radiolabelled SCH-23390 ([N-methyl-3H ] R(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-1H-3-benzazepine 70.3 Ci/mmol) with 100-fold excess ketanserin (40 nM) to block 5-HT 2 receptors and prevent their labelling by the radioligand (Billard et al., 1984 ; Van Tol et al., 1991) . Non-specific binding was determined with excess (1 mM) cis-flupentixol.
The D 3 receptor is predominantly expressed in the ventral striatum and ventral tegmental area (VTA)/ substantia nigra (SN) (Sokoloff et al., 1990) , therefore only slides containing these regions were used from the PD 7-lesioned rats to measure D 3 receptors. Sections were preincubated three times for 5 min in 50 mM sodium-Hepes buffer (pH 7.5), containing 1 mM EDTA and 0.1 % BSA. Sections were then incubated at room temperature for 45 min in fresh buffer containing 0.2 nM radiolabelled trans-7-OH-PIPAT (Doherty and Gratton, 1997) R(+)trans-7-hydroxy-2-[N-propyl-N-(3k-iodo-2k-propenyl)amino] tetralin ; 2000 Ci/mmol). Non-specific binding was determined with excess (1 mM) DA. After incubation slides were washed four times for 2 min in ice-cold sodium-Hepes containing 100 mM NaCl buffer, dipped in ice-cold water and dried under a stream of cold air (Diaz et al., 2000) .
For the cannabinoid receptor, slides were preincubated for 2 h at 37 xC in 50 mM Tris-HCl buffer (pH 7.4), with 5 % BSA, containing 1-10 nM 3 H]Hyperfilm (Amersham, Diegem, Belgium) in light-tight cassettes at room temperature. Slides of the lesioned and sham-operated groups were laid down against the same film. After a period of 4-5 wk the films were developed using Kodak D19 developer (5 min) followed by rinsing in demineralized water and fixed with Kodak rapid fix (5 min) and analysed in parallel.
[
125 I] labelling slides and scales (Amersham) were apposed to biomax MR films (Amersham) for 2 wk. The two lesion day groups (PD 7 and PD 21) and all ligands were processed in two separate experiments, with separate incubations and development. The rats within lesion day group were treated identically.
Image analysis
Quantitative analysis of receptor binding autoradiograms was carried out by video-based computerized densitometry using a MCID image analyser (Imaging Research, Ontario, Canada). Tissue equivalents (fmol/mg) for receptor binding were derived from microscale-based calibrations after subtraction of non-specific binding images. As regions of interest were selected, those regions in which either the D 1 -like or the D 2 -like receptor density exceeded 20 fmol/mg tissue, a lower density was regarded as unreliable with respect to probable lesion effects. Regions were identified according to the atlas of Paxinos and Watson (2004) . The olfactory tubercle (OT), nucleus accumbens core (NAcC), nucleus accumbens shell (NAcS), anterior caudate putamen (CPu) and SN were analysed by freehand drawing of the selected structures. The central, medial and lateral portions of the anterior CPu [CPu cent, CPu med, CPu lat, respectively] and the central grey (CG) were analysed by sampling with a box tool. For each region three quantified measures were taken from both right and left side of successive brain sections, except for the CG which was measured in the centre.
Neurochemical analysis
Rats that were ibotenic acid-and sham-lesioned at PD 7 were used for this experiment. Tissue concentrations of DA, 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA), NA, 3-methoxy-4-hydroxyphenylglycol (MHPG) and 5-HIAA were determined on PD 64 in a separate group of rats. At PD 64 rats were transported to a room adjacent to the decapitation room, taken to the decapitation room per cage and decapitated. Brains were removed, frozen in isopentane (x25 xC), and stored at x80 xC. Serial slices y1.5 mm thick were performed in a cold box at x15 xC.
Tissue punches were made bilaterally in the mPFC (infralimbic cortex, prelimbic cortex), nucleus accumbens (NAc), and CPu using 2.0 mm (i.d.) stainless steel tubing. Cryosections (20 mm) were prepared from posterior parts of the brain that included the amygdala, and stained with haematoxylin acid/eosin. Only brains from rats in which a bilateral amygdala lesion was confirmed (see selection procedure) were selected for analysis. Tissue punches were homogenized in 120 ml ice-cold 0.5 N perchloric acid and then centrifuged at y5000 rpm at 4 xC for 30 min. Supernatant was removed and neutralized with 3 ml 4.4 N sodium acetate per 100 ml perchloric acid (pH between 3 and 5). The protein content of the tissue pellet was determined with a BCA protein assay (Pierce, Rockford, IL, USA). Aliquots (two samples) of the supernatant were injected into a high-performance liquid chromatograph system (HPLC) (pump 2010 ; Pharmacia, Woerden, The Netherlands) with an autosampler (Gilson model 231 XL, Meyvis, Bergen op Zoom, The Netherlands) to determine DA, DOPAC, HVA, NA, 5-HIAA and MHPG levels. The HPLC system was equipped with a reversed phase column (Inertsil ODS 3 ; Aurora Borealis Control, Schoonebeek, The Netherlands) and a Decade electrochemical detector and cell (Antec Leyden BV, Leiden, The Netherlands) and was set at a potential of 750 mV vs. Ag/AgCl reference electrode. A column oven set at 30 xC, integrated in the Decade, was used for both the reversed phase column and the electrochemical cell. The mobile phase consisted of sodium acetate, EDTA (100 mg/l), OSA (150 mg/l), concentrated acetic acid (2.85 ml/l) and MeOH (75 ml/l), adjusted to pH 4.6 with acetic acid. Flow rate was 0.40 ml/min. For data acquisition, the software package Chromeleon 4.32 (Gynkotek Separations, Hendrik Ido Ambacht, The Netherlands) was used.
Statistical analyses
The behavioural data were analysed with a two-way ANOVA [with factors lesion (lesioned vs. shamoperated animals) and age-at-lesion (PD 7 vs. PD 21 animals)]. Further analyses was performed using oneway ANOVA (with factor lesion). Behavioural data are presented as means¡S.E.M.
For the autoradiographic data, first left-right differences per area were assessed using a paired Student's t test. No differences were observed and data were averaged, thus resulting in one observation per region per animal. Analysis was performed using a two-way ANOVA (with factors lesion and age-at-lesion). Further analysis was performed using a one-way ANOVA (with factor lesion). Autoradiographic data are presented as mean specific binding in fmol/mg tissue. Binding data of individual rats are expressed as percentage of the mean value obtained in sham-operated rats at PD 7 or PD 21.
For the neurochemical analysis the duplicate aliquots of punch supernatant were pooled. As no left-right differences were observed the data of the individual animals were averaged resulting in one observation per region per animal. Concentration of DA, NA and its metabolites, and, in a separate analysis using the data of individual animals, DA turnover were analysed by one-way ANOVA (with factor lesion). All data are presented as means (pmol/mg protein¡S.E.M.).
A significance level of p<0.05 was used for all analyses. In a few cases no data were available due to a technical problem.
Results
Lesion verification
Twenty-six animals with excitotoxic lesions were used in the present study (for autoradiographic analysis : n=8 per group, two groups ; for neurochemical analysis : n=10) and 26 sham-lesioned animals served as controls. The lesioned rats had bilateral amygdala damage, which was visible in the stained sections as neuronal loss or gliosis in parts of the amygdala complex (Fig. 1a-c) . This was consistent with previous reports (Daenen et al., , 2002a . In all rats the basolateral nucleus of the amygdala was affected, while in some rats the damage extended to other amygdaloid nuclei and in two rats small parts of the rostral aspects of the hippocampus were affected. There were no differences between the lesions made at PD 7 and those made at PD 21.
Behaviour
The behavioural data of rats revealed a significant lesion and age-at-lesion interaction for the frequency of ambulations [F(1, 44)=8.0, p=0.007]. The neonatal amygdala-lesioned rats were hyperactive in response to a novelty challenge, compared to the age-matched sham-operated controls [F(1, 31)=30.1, p<0.001] (Figure 2 ). Such an effect was absent in animals operated on at PD 21 [F(1, 13)=0.8, n.s.]. No significant effect was observed for the frequency and duration of rearing, grooming, and sniffing.
Autoradiography
In-vitro autoradiography for DA receptors, the D 2 -like and D 1 -like receptors, revealed highly specific binding in the analysed areas (91 % for D 2 -like and 89 % for D 1 -like receptors) ( Table 1) . A representative autoradiograph is presented in Figure 1d . The specific binding for the D 3 receptor was high (91 %) ( Table 2 ). The cannabinoid (CB 1 ) receptor binding was also highly specific (89 %) in the analysed areas (Table 1 , autoradiograph, Figure 1e ). (Gingrich and Caron, 1993) . The D 4 receptor is hardly expressed in mesolimbic projection regions (Oak et al., 2000) , in contrast to the D 3 receptor (Sokoloff et al., 1990) . The neonatal amygdala lesion had no effect Cannabinoid receptors (Figure 3c ). For the CPu and the subareas CPu cent and CPu med, and CG, ANOVA revealed a significant lesionrage-at-lesion interaction for the CB 1 receptor binding [CPu : F(1, 26)=5.5, p=0.027 ; CPu cent F(1, 26)=8.3, p=0.008 ; CPu med F(1, 26)=5.5, p<0.027 ; CG : F(1, 28)=5.9, p=0.022). Post-hoc tests revealed that the neonatally lesioned rats had increased CB 1 receptor binding in these areas compared with age-at-lesion matched sham controls [F(1, 15)] (CPu : 18.8, p=0.001 ; CPu cent : 13.4, p=0.002 ; CPu med : 13.1, p=0.002 ; CG=29.0, p<0.001). No interaction and main lesion effects were observed in the CPU lat, OT, NAcC, NAcS and SN except for a main lesion effect in the SN [F(1, 28)=6.1, p=0.02]. This latter effect was mainly due to a reduced CB 1 receptor binding in the PD 7-lesioned animals [F(1, 15)=7.7, p=0.015]. There were no differences in the CB 1 receptor binding between PD 21-lesioned and sham-lesioned rats.
Neurochemical analysis
Data of the neonatally lesioned rats were compared with their sham-operated controls. Concentrations of DA, NA and its metabolites and of 5-HIAA in the mPFC, NAc and CPu are shown in Figure 4 . Dopamine. In the NAc the concentration of DA was decreased [F(1, 17)=5.6, p=0.03], while the concentrations of the DA metabolites were not affected by the neonatal lesion. The ratio DOPAC/DA was 
Discussion
The present study shows that following a neonatal amygdala lesion (PD 7), but not following a similar lesion at a later age (PD 21), the density of the D 2 -like receptors, and to a lesser extent that of the D 1 -like receptors, was reduced in specific brain areas in adult rats. The density was reduced in the core and shell of the NAc, the OT, SN and CG. Neonatal amygdala lesions did not affect the density of the D 1 -and D 2 -like receptors in the various parts of the CPu. The D 2 -like receptor group consists of the D 2 , D 3 , and D 4 receptors (Civelli et al., 1993 ; Gingrich and Caron, 1993) . The expression level of the D 4 receptor is very low in the NAc and OT (Oak et al., 2000 ; Tarazi et al., 1997) , while the D 3 receptor is readily expressed in these regions (Sokoloff et al., 1990) . However, the density of D 3 receptor in the OT, NAc and CPu was not changed in the neonatally amygdala-lesioned animals. Therefore, it is likely that the observed reduction in D 2 -like receptors is due to a reduction of the expression level of the D 2 receptor. The observed effects on DA receptor density were localized in specific parts of the mesencephalic DA systems. D 1 -and D 2 -like receptors were reduced in the OT and NAc, projection areas of the mesolimbic lesions. Thin error bars represent errors of sham-operated rats, thick error bars represent errors of lesioned rats ; * pf0.002, ** pf0.001 compared to age-at-lesion matched sham-operated animals (n=8 per age per treatment group). OT, olfactory tubercle ; NAcC, nucleus accumbens core ; NAcS, nucleus accumbens shell ; CPu, caudate putamen ; SN, substantia nigra ; CG, central grey.
DA system, but not in the CPu, a target area of the nigrostriatal DA system. This differential effect may be mediated by the functional aberrations in the mPFC, probably induced by the neonatal basolateral amygdala lesion (Bouwmeester et al., 2002a,b) . The mPFC projects predominantly to the OT and NAc but not to the CPu (Groenewegen et al., 1997) , and manipulations in the mPFC have been shown to affect the DA system in the NAc (Carr and Sesack, 2000 ; Jackson and Moghaddam, 2001) . DA receptor density was also decreased in the SN, a cell body area of the mesencephalic DA systems. Receptor density in the VTA was not measured, because of low amounts of receptors present (see also Mansour et al., 1990) . Traditionally the VTA is thought to be part of the mesolimbic DA system while the SN is part of the nigrastriatal system. However, anatomical data indicate that this division is not that strict (Joel and Weiner, 2000 ; Tzschentke, 2001) . DA receptors are located pre-and post-synaptically. In the VTA/SN area the D 2 receptors are located on dopaminergic somatodendritic sites and serve as autoreceptors (Chen and Pan, 2000) and the D 1 receptor is found on striatal afferents (Kalivas, 1993) . In the mesolimbic and nigrastriatal systems both the D 1 and D 2 receptors are present post-synaptic, most prominently on the (GABAergic) medium spiny projection sites, but also on the (cholinergic) interneurons (CPu), (e, f) medial prefrontal cortex (mPFC). Grey bars represent sham-operated rats ; dark bars represent lesioned rats ; * p<0.05 compared to sham-operated animals (n=10 per group) ; note the different scale of (e) vs. (a) and (c). (Mansour et al., 1990 ; Sesack and Pickel, 1990 ; Smith and Kieval, 2000) . The D 2 receptor is also thought to be expressed presynaptically on DA and possibly cortical terminals (Smith and Kieval, 2000) , although some authors claim that this is the D 3 receptor (Diaz et al., 2000) . Thus, neonatal basolateral amygdala lesion affects the mesolimbic DA receptors in the mesolimbic area, and in particular those localized post-synaptically.
The reduced density of D 2 receptors following the neonatal amygdala lesions could be due to several factors. One important factor may be chronically altered DA neurotransmission (Chen et al., 1993) . We found that the reduced density of D 2 receptors in the NAc is accompanied by decreased levels of DA and unaltered levels of the DA metabolites DOPAC and HVA, whereas in the CPu these parameters were unaffected. Decreased levels of DA and unchanged levels of DA metabolites suggest increased DA turnover and neurotransmission, which may result in decreased DA receptor density. However, the relation between decreased density of the DA receptor and increased DA turnover have to be established before definite conclusions can be drawn. Moreover, we measured at one time-point only and other neonatal lesion experiments have indicated that dynamic processes can occur in the DA system during development (Zhang et al., 2002) .
In all three regions analysed (i.e. mPFC, NAc and CPu) noradrenergic neurotransmission seems to be decreased as evidenced by decreased levels of NA and its metabolite MHPG (the level of MHPG in the mPFC was below detection level). Since this effect was present throughout the three areas, the neonatal amygdala lesion may affect the activity of the NA neurons at the cell body level, but more experiments are needed before conclusions can be reached. The concentration of the serotonin metabolite 5-HIAA was not affected in any of the three areas studied, further supporting the specificity of the observed effects.
In contrast to the density of DA receptors, the density of the cannabinoid receptor CB 1 was not changed in the OT and core and shell of the NAc but increased in the CPu. In agreement with previous data, high levels of CB 1 receptors were observed in the local ganglia regions (e.g. CPu and SN) (Herkenham et al., 1990 (Herkenham et al., , 1991 . Detailed localization studies have revealed that the CB 1 receptor was present in both neurons and fibres in the CPu, while in the SN only CB 1 -positive fibres were observed (Moldrich and Wenger, 2000 ; Tsou et al., 1998) . Interestingly, CB 1 -receptor levels increased following a neonatal lesion of the basolateral amygdala in regions in which the CB 1 receptor is present on neurons (CPu) and decreased in a region where only CB 1 -positive fibres are present (SN).
The present study reveals that timing of the lesion is important for the change in density of DA and cannabinoid receptors. The receptors levels were reduced following a lesion at PD 7 but not following a comparable lesion at PD 21. That timing of the lesion is important was also shown by behavioural studies with the same paradigm. Rats with a neonatal basolateral amygdala lesion showed more pronounced locomotor stereotypy and decreased habituation after puberty, had a disrupted prepulse inhibition of the startle response and some aspects of their social behaviour were disrupted. In contrast, rats with a lesion at PD 21 behaved normally, with the exception of some aspects of social behaviours (Daenen et al., , 2002a (Daenen et al., ,b, 2003a Diergaarde et al., 2004 ; Wolterink et al., 2001 ). The present study confirms previous reports that the PD 7-lesioned rats have a hyperlocomotor response to novelty, which was not observed in rats lesioned at PD 21 (Daenen et al., 2002a ; Wolterink et al., 2001) . The importance of timing of the lesion is further indicated by experience with another neonatal limbic lesion model, the ventral hippocampus lesions. Wood and co-workers (1997) showed that lesions at PD 3 and PD 7 have comparable behavioural effects which arise after puberty, while lesions at PD 14 resulted in behaviour comparable with that after adult lesions. Anatomical data further substantiate that the time of the lesion can be important for the observed effects later in life. After PD 7 the reciprocal innervation of the mPFC and the basolateral amygdala still changes substantially (Bouwmeester et al., 2002a,b ; Verwer et al., 1996) and also the cytoarchitectural properties of the PFC mature after PD 7 (Van Eden and Uylings, 1985) . The amygdaloid innervation to the NAc and thalamus on the other hand does not seem to change noticeably over the first postnatal weeks (Bouwmeester et al., 2002a,b) . This prompts us to propose that the observed effects of D 1 , D 2 -like and CB 1 receptors are caused by an aberrant neurodevelopment following a neonatal basolateral amygdala lesion.
The neonatal amygdala, and also the ventral hippocampus model have been proposed as neurodevelopmental models for diseases like schizophrenia and autism (Lipska and Weinberger, 2000 ; Wolterink et al., 2001) . Putting forward an animal model for these diseases can meet reasonable scepticism as to how accurately animal behaviours and (patho)physiology can be reflective of such complex human disorders (Krystal et al., 1999 ; Lipska and Weinberger, 2000) .
Nevertheless, some remarks can be made about the present data in relation to findings in schizophrenia, although less is known in this respect for autism. In the neonatal amygdala model, the effects on the DA system were confined to the mesolimbic system and were absent in the striatal system. Human studies have revealed that the antipsychotic effect of therapeutics is probably related to blockade of D 2 receptors in the mesolimbic DA system, whereas the extrapyramidal side-effects of these drugs are linked to blockade in the nigrastriatal system (Deutch et al., 1990) . Altered D 2 -receptor levels have been implicated in hypotheses of schizophrenia (Duncan et al., 1999 ; Laruelle et al., 1996 ; Seeman, 1987) . However, in-vivo brain imaging data from non-medicated patients were inconsistent (Farde et al., 1990 ; Nordstrom et al., 1995 ; Seeman and Kapur, 2000) . Although the exact function and role of D 2 receptors is not yet clear, blockade of these receptors remains a necessary and sufficient condition for antipsychotic action of therapeutics (Kapur and Seeman, 2001) . Recently, the relation between cannabis and schizophrenia has been a matter of debate. Cannabis use in itself increases cannabinoid receptor densities in the CPu of both schizophrenics and controls (Dean et al., 2003 ; Krystal et al., 1999) . Recent clinical studies are supportive of the hypothesis that cannabis use was associated with an almost threefold increased relative risk of developing schizophrenia (Arsenault et al., 2002 ; Semple et al., 2005 ; Sheldon, 2003) . The data so far suggest that in subjects vulnerable for developing schizophrenia, cannabis use dose-dependently increased the risk for schizophrenia and particularly when used during early adolescence (see Semple et al., 2005) . The present study showing increased density of the cannabinoid receptors in an animal model for schizophrenia provides a neurochemical basis for the interaction between vulnerability and cannabis use. Supporting evidence are the observations that in schizophrenics endogenous cannabinoids were increased in the cerebrospinal fluid and the density of cannabinoid receptors (CB 1 ) enhanced in the dorsolateral PFC and anterior cingulate cortex (Dean et al., 2003 ; Leweke et al., 2001 ; Zavitsanou et al., 2004) . Whether these changes are causally related to schizophrenia or reflect, for example, a compensatory adaptation to the disease state is yet unclear (Giuffrida et al., 2004 ; Hall, 2006) . Interestingly, preliminary findings in our animal model also showed increased CB 1 -receptor binding in cortical areas particularly the orbital cortex and PFC in PD 7-, but not PD 21-lesioned animals. Whether the reported interaction between endogenous cannabinoids and DA (Rodriguez De Fonseca et al., 2001 ; Van der Stelt and Di Marzo, 2003) is of relevance for the present model and the disease schizophrenia is not yet clear. It should be emphasized that the changes in CB 1 receptors and DA receptors are in the nigrostriatal and mesolimbic system respectively, which could suggest differential involvement in psychiatric and motoric symptoms, which may or may not be modulated by antipsychotic treatments.
Intriguingly, noradrenergic neurotransmission was decreased in the present model. The role of noradrenergic neurotransmission in normal cognitive functions has been extensively studied. In schizophrenia both increased and decreased levels of noradrenergic neurotransmission have been observed (Friedman et al., 1999 ; Yamamoto and Novotney, 1998) . Atypical neuroleptics activate noradrenergic neurons in the locus coeruleus in rats (Dawe et al., 2001 ). The present data may stimulate further studies on brain NA and schizophrenia.
The present findings add to the existing literature on neonatal excitotoxic damage of the medial temporal lobe. Also in the other model, e.g. the ventral hippocampus, evidence has been presented for a disturbed prefrontal-accumbal circuit (Alquicer et al., 2004 ; Goto and O'Donnell, 2004 ; Lipska and Weinberger, 2000 ; Lipska et al., 2003a,b) . Recently, we showed that PD 7 basolateral amygdala lesions disrupt performance on mPFC-related tasks, deficits that were absent in the PD 21-lesioned animals (Diergaarde et al., 2005) . Accordingly, reduced mPFC activity has been shown to predict an exaggerated dopaminergic function in schizophrenia (Meyer-Lindenberg et al., 2002) , indicating the linkage of altered neurodevelopment and aberrant functioning of DA systems. The data obtained in our animal model may stimulate further elucidation of the amygdaloid-prefrontal-NAc regulatory mechanisms and ultimately provide new insight into the pathogeneses of neurodevelopmental disorders such as schizophrenia.
